Linda Clare1,2,3, Julia C Teale4, Gill Toms5, Aleksandra Kudlicka1,2, Isobel Evans1, Sharon Abrahams6, Laura H Goldstein7, John V Hindle1, Aileen K Ho8, Marjan Jahanshahi9, Dawn Langdon10, Robin Morris7, Julie S Snowden11, Rhys Davies12, Ivana Markova13, Monica Busse14, Jo Thompson-Coon2. 1. Centre for Research in Ageing and Cognitive Health, University of Exeter, Exeter, UK. 2. PenCLAHRC, University of Exeter Medical School, Exeter, UK. 3. Centre for Research Excellence in Cognitive Health, Australian National University, Canberra City, ACT, Australia. 4. Fettes College, Edinburgh, UK. 5. Wales School for Social Care Research, Bangor University, Bangor, Wales, UK. 6. Psychology-PPLS and Euan MacDonald Centre for Motor Neurone Disease Research, The University of Edinburgh, Edinburgh, Scotland, UK. 7. King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK. 8. School of Psychology and Clinical Language Sciences, University of Reading, Reading, UK. 9. Institute of Neurology, University College London, London, UK. 10. Department of Psychology, Royal Holloway University of London, London, UK. 11. Cerebral Function Unit, Salford Royal NHS Foundation Trust, Salford, UK. 12. Walton Centre NHS Foundation Trust, Liverpool, UK. 13. Hull York Medical School, University of Hull, Hull, UK. 14. School of Medicine, Cardiff University, Cardiff, Wales, UK.
Abstract
BACKGROUND: Despite its potentially significant impact, cognitive disability may be overlooked in a number of progressive neurodegenerative conditions, as other difficulties dominate the clinical picture. OBJECTIVE: We examined the extent, nature and range of the research evidence relating to cognitive rehabilitation, self-management, psychotherapeutic and caregiver support interventions in Parkinsonian disorders, multiple sclerosis (MS), frontotemporal dementias (FTD), motor neuron disease and Huntington's disease. METHODS: Scoping review based on searches of MEDLINE and CINAHL up to 15 March 2016. RESULTS: We included 140 eligible papers. Over half of the studies, and almost all the randomised controlled trials, related to MS, while a number of single case studies described interventions for people with FTD. CR interventions addressed functional ability, communication and interaction, behaviour or memory. The majority of psychotherapy interventions involved cognitive behavioural therapy for depression or anxiety. Self-management interventions were mainly available for people with MS. There were few reports of interventions specific to caregivers. Numerous methodological challenges were identified. CONCLUSIONS: The limited range of studies for all conditions except MS suggests a need firstly to synthesise systematically the available evidence across conditions and secondly to develop well-designed studies to provide evidence about the effectiveness of CR and other psychological interventions.
BACKGROUND: Despite its potentially significant impact, cognitive disability may be overlooked in a number of progressive neurodegenerative conditions, as other difficulties dominate the clinical picture. OBJECTIVE: We examined the extent, nature and range of the research evidence relating to cognitive rehabilitation, self-management, psychotherapeutic and caregiver support interventions in Parkinsonian disorders, multiple sclerosis (MS), frontotemporal dementias (FTD), motor neuron disease and Huntington's disease. METHODS: Scoping review based on searches of MEDLINE and CINAHL up to 15 March 2016. RESULTS: We included 140 eligible papers. Over half of the studies, and almost all the randomised controlled trials, related to MS, while a number of single case studies described interventions for people with FTD. CR interventions addressed functional ability, communication and interaction, behaviour or memory. The majority of psychotherapy interventions involved cognitive behavioural therapy for depression or anxiety. Self-management interventions were mainly available for people with MS. There were few reports of interventions specific to caregivers. Numerous methodological challenges were identified. CONCLUSIONS: The limited range of studies for all conditions except MS suggests a need firstly to synthesise systematically the available evidence across conditions and secondly to develop well-designed studies to provide evidence about the effectiveness of CR and other psychological interventions.
Authors: Catharina Muente; Ann-Kristin Folkerts; Elke Kalbe; Franziska Thieken; Laura-Elisa Assmann; Maria Widritzki; Carsten Eggers; David Pedrosa; Marcel Wilhelm Journal: Brain Sci Date: 2022-03-26
Authors: Hanna Malmberg Gavelin; Amit Lampit; Harry Hallock; Julieta Sabatés; Alex Bahar-Fuchs Journal: Neuropsychol Rev Date: 2020-04-07 Impact factor: 7.444
Authors: Sietske A M Sikkes; Yi Tang; Roos J Jutten; Linda M P Wesselman; Lyn S Turkstra; Henry Brodaty; Linda Clare; Erin Cassidy-Eagle; Kay L Cox; Gaël Chételat; Sophie Dautricourt; Klodian Dhana; Hiroko Dodge; Rose-Marie Dröes; Benjamin M Hampstead; Thomas Holland; Amit Lampit; Kate Laver; Antoine Lutz; Nicola T Lautenschlager; Susan M McCurry; Franka J M Meiland; Martha Clare Morris; Kimberly D Mueller; Ruth Peters; Gemma Ridel; Aimee Spector; Jenny T van der Steen; Jeanette Tamplin; Zara Thompson; Alex Bahar-Fuchs Journal: Alzheimers Dement Date: 2020-11-20 Impact factor: 21.566